ISOFOL.ST
Price:
$0.739
Market Cap:
$207.74M
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.
Industry
Biotechnology
IPO Date
2017-04-04
Stock Exchange
STO
Ticker
ISOFOL.ST
According to Isofol Medical AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -2.84. This represents a change of -39.80% compared to the average of -4.72 of the last 4 quarters.
The mean historical PE Ratio of Isofol Medical AB (publ) over the last ten years is -9.65. The current -2.84 PE Ratio has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), ISOFOL.ST's PE Ratio was at its highest in in the March 2020 quarter at -0.78. The PE Ratio was at its lowest in in the September 2018 quarter at -23.97.
Average
-9.65
Median
-8.66
Minimum
-19.52
Maximum
-0.75
Discovering the peaks and valleys of Isofol Medical AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 324.33%
Maximum Annual PE Ratio = -0.75
Minimum Annual Increase = -87.10%
Minimum Annual PE Ratio = -19.52
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -8.22 | 159.06% |
| 2023 | -3.17 | 324.33% |
| 2022 | -0.75 | -87.10% |
| 2021 | -5.80 | -36.34% |
| 2020 | -9.11 | 29.06% |
| 2019 | -7.06 | -55.89% |
| 2018 | -16.00 | 6.89% |
| 2017 | -14.97 | 25.23% |
| 2016 | -11.95 | -38.76% |
| 2015 | -19.52 | -73.95% |
The current PE Ratio of Isofol Medical AB (publ) (ISOFOL.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.05
5-year avg
-5.41
10-year avg
-9.65
Isofol Medical AB (publ)’s PE Ratio is greater than Annexin Pharmaceuticals AB (publ) (-3.84), less than IRLAB Therapeutics AB (publ) (-2.14), greater than Lipum AB (publ) (-4.85), greater than Initiator Pharma A/S (-11.41), less than Karolinska Development AB (publ) (-0.67), less than Enorama Pharma AB (publ) (-2.42), greater than Bio-Works Technologies AB (publ) (-6.37), greater than Clinical Laserthermia Systems AB (publ) (-5.02), greater than Alzinova AB (publ) (-7.44), less than Xbrane Biopharma AB (publ) (1.93),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.84 | $162.36M | |
| -2.14 | $196.87M | |
| -4.85 | $310.76M | |
| -11.41 | $214.94M | |
| -0.67 | $89.54M | |
| -2.42 | $184.98M | |
| -6.37 | $186.49M | |
| -5.02 | $192.73M | |
| -7.44 | $200.09M | |
| 1.93 | $115.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Isofol Medical AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Isofol Medical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Isofol Medical AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Isofol Medical AB (publ) (ISOFOL.ST)?
What is the highest PE Ratio for Isofol Medical AB (publ) (ISOFOL.ST)?
What is the 3-year average PE Ratio for Isofol Medical AB (publ) (ISOFOL.ST)?
What is the 5-year average PE Ratio for Isofol Medical AB (publ) (ISOFOL.ST)?
How does the current PE Ratio for Isofol Medical AB (publ) (ISOFOL.ST) compare to its historical average?